A clear-cut tech strategy is critical for sites in this technology-heavy climate, yet many function without one, opening them up for inefficiencies, extra burden, disconnects and overall fatigue, warns one site network expert whose organization developed an approach that systematically evaluates, implements and cyclically reassesses its tech solutions. Read More
In this time of growing trial complexity, the use of patient advisory boards is critical to improving the patient and site trial experience — but just a small fraction of protocols currently use them, according to two WCG experts. Read More
The top challenges named by sites in a recent WCG Clinical survey — staffing, recruitment, trial complexity and others — are not new but are increasingly impacting sites’ ability to take on new trials, the survey says. Read More
The FDA’s long-awaited draft guidance on decentralized trials (DCT) is finally out and industry has been abuzz with discussion. Experts feel it has arrived at a pivotal moment for clinical research and does many things right, but some recommendations may draw industry pushback. Read More
The clinical research industry is falling behind the innovation curve, says Ken Getz, executive director of the Tufts Center for the Study of Drug Development (CSDD), taking years — and sometimes decades — to evaluate, adopt and fully implement new technologies and methods. Read More
The University of North Carolina at Chapel Hill (UNC) School of Medicine’s innovative web-based solution to managing their trials’ startup processes was crowned the winner of this year’s Innovation Challenge at the 2023 MAGI East Clinical Research Conference in Philadelphia. Read More
Great progress has been made in the movement to improve diversity, equity and inclusion (DE&I) in clinical research, but experts say more work is needed improving trust and scaling down to the community level to continue making strides. Read More
Sponsors should build risk-based quality management (RBQM) into their trials as if they were constructing a house from the basement up, advises the director of the FDA’s Office of Bioresearch Monitoring Operations. Read More
Sites venturing into the growing field of digital therapeutics (DTx) need the appropriate infrastructure, tech know-how and adaptability, while sponsors need to be willing to offer training/support, iron out hurdles that come with remote components and simplify these trials whenever possible, a clinical research expert advises. Read More
DALLAS — With the clinical research workforce dwindling, it’s never been more important for sites and sponsors to “sell” themselves to job candidates, according to one talent acquisition expert who advocates knowing your organization’s true value. Read More